Nanoparticles for drug delivery in Parkinson's disease

被引：30
作者：
Baskin, Jonathan [1 ]
Jeon, June Evelyn [1 ]
Lewis, Simon J. G. [1 ]
机构：
[1] Univ Sydney, Parkinsons Dis Res Clin, Brain & Mind Ctr, Camperdown, NSW, Australia
来源：
JOURNAL OF NEUROLOGY | 2021年 / 268卷 / 05期
基金：
英国医学研究理事会; 澳大利亚国家健康与医学研究理事会;
关键词：
Nanoparticles; Parkinson’ s disease; Blood– brain barrier; Targeted delivery; Polymeric nanoparticles; Lipid-based nanoparticles; Inorganic nanoparticles; NANOSTRUCTURED LIPID CARRIERS; BLOOD-BRAIN-BARRIER; LOADED CHITOSAN NANOPARTICLES; PEG-PLGA NANOPARTICLES; ALPHA-SYNUCLEIN; GENE-THERAPY; LACTOFERRIN RECEPTORS; INTRANASAL DELIVERY; GOLD NANOPARTICLES; RAT MODEL;
D O I：
10.1007/s00415-020-10291-x
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Although effective symptomatic treatments for Parkinson's disease (PD) have been available for some time, efficient and well-controlled drug delivery to the brain has proven to be challenging. The emergence of nanotechnology has created new opportunities not only for improving the pharmacokinetics of conventional therapies but also for developing novel treatment approaches and disease modifying therapies. Several exciting strategies including drug carrier nanoparticles targeting specific intracellular pathways and structural reconformation of tangled proteins as well as introducing reprogramming genes have already shown promise and are likely to deliver more tailored approaches to the treatment of PD in the future. This paper reviews the role of nanoparticles in PD including a discussion of both their composition and functional capacity as well as their potential to deliver better therapeutic agents.
引用
收藏
页码：1981 / 1994
页数：14
相关论文
共 123 条
[71]   New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases [J].
Nunez, Marco T. ;
Chana-Cuevas, Pedro .
PHARMACEUTICALS, 2018, 11 (04)
[72]   Long, Needle-like Carbon Nanotubes and Asbestos Activate the NLRP3 Inflammasome through a Similar Mechanism [J].
Palomaki, Jaana ;
Valimaki, Elina ;
Sund, Jukka ;
Vippola, Minnamari ;
Clausen, Per Axel ;
Jensen, Keld Alstrup ;
Savolainen, Kai ;
Matikainen, Sampsa ;
Alenius, Harri .
ACS NANO, 2011, 5 (09) :6861-6870
[73]   Improved brain pharmacokinetics following intranasal administration of N,N,N-trimethyl chitosan tailored mucoadhesive NLCs [J].
Pardeshi, Chandrakantsing, V ;
Belgamwar, Veena S. .
MATERIALS TECHNOLOGY, 2020, 35 (05) :249-266
[74]   New Developments in Liposomal Drug Delivery [J].
Pattni, Bhushan S. ;
Chupin, Vladimir V. ;
Torchilin, Vladimir P. .
CHEMICAL REVIEWS, 2015, 115 (19) :10938-10966
[75]   Parkinson's disease: Current drug therapy and unraveling the prospects of nanoparticles [J].
Paul, Ankita ;
Yadav, Khushwant S. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 58
[76]   Dopamine-loaded blood exosomes targeted to brain for better treatment of Parkinson's disease [J].
Qu, Mengke ;
Lin, Qing ;
Huang, Luyi ;
Fu, Yao ;
Wang, Luyao ;
He, Shanshan ;
Fu, Yu ;
Yang, Shengyong ;
Zhang, Zhirong ;
Zhang, Ling ;
Sun, Xun .
JOURNAL OF CONTROLLED RELEASE, 2018, 287 :156-166
[77]   A brain targeting functionalized liposomes of the dopamine derivative &ITN&IT-3, 4-bis(pivaloyloxy)-dopamine for treatment of Parkinson's disease [J].
Qu, Mengke ;
Lin, Qing ;
He, Shanshan ;
Wang, Luyao ;
Fu, Yao ;
Zhang, Zhirong ;
Zhang, Ling .
JOURNAL OF CONTROLLED RELEASE, 2018, 277 :173-182
[78]  
Rafiyath SM, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-10
[79]   Pramipexole dihydrochloride loaded chitosan nanoparticles for nose to brain delivery: Development, characterization and in vivo anti-Parkinson activity [J].
Raj, Ruhi ;
Wairkar, Sarika ;
Sridhar, Vinay ;
Gaud, Ram .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2018, 109 :27-35
[80]   Polysorbate 80 coated crosslinked chitosan nanoparticles of ropinirole hydrochloride for brain targeting [J].
Ray, Somasree ;
Sinha, Pratyusha ;
Laha, Bibek ;
Maiti, Sabyasachi ;
Bhattacharyya, Uttam Kumar ;
Nayak, Amit Kumar .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 48 :21-29
3456789101112